Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized phase 3 study of IVIG (GGS) in Churg–Strauss syndrome / allergic granulomatous angiitis with neuropathy
jRCT2080220238Phase 3
- Sponsor
- Teijin Pharma
- Start
- May 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of immune globulin in eosinophilic granulomatosis with polyangiitis (EGPA) and peripheral neuropathy (2 arms), sponsored by Teijin Pharma.
02
Drugs
immune globulin
03
Conditions
eosinophilic granulomatosis with polyangiitis (EGPA)peripheral neuropathy
Beyond the preview
Go deeper on jRCT2080220238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220238.